GGrantIndex
Sort

78,016 grants matching breast cancer

Breast Cancer Detection Consortium

$438,654
Jeffrey R. Marks · Duke University · U01 · FY2020 · CA

New Method of SNP Typing in Aging Related Disorders

$438,640
Seashell Technology, Llc · R44 · FY2002 · AG

SIGNAL TRANSDUCTION BY ERBB2/ERBB3 OLIGOMERS

$438,624
Linda Joy Pike · Washington University · R01 · FY2014 · GM

Gene Copy Number Changes and Breast Cancer Survival

$438,619
Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA

IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

$438,609
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

SYNTHESIS OF ANTITUMOR NATURAL PRODUCTS

$438,551
Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · CA

ENZYMES IN ORGANIC SYNTHESIS

$438,548
Chi-Huey Wong · Scripps Research Institute, The · R37 · FY2008 · GM

Vanderbilt Network Lead Academic Participating Site for the NCTN

$438,545
Kristen Keon Ciombor · Vanderbilt University Medical Center · UG1 · FY2025 · CA

Engineering Responsive Chemical Heterogeneity in Protein Vesicles for Simultaneous Delivery of Diverse Cargoes

$438,521
Julie Champion · Georgia Tech Research Corporation · · FY2021 · MPS

Combined magnetophoresis and photodynamic therapy for the treatment of TNBC

$438,479
Andrew Tsourkas · University Of Pennsylvania · R01 · FY2024 · EB

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

$438,472
Michael R Irwin · University Of California Los Angeles · R01 · FY2007 · CA

Dual-pronged nano-drug delivery using plant virus-like particles.

$438,466
Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2018 · CA

Combination of Radiation with Multi-Target Molecular Therapy for Cancer

$438,452
Jacek Capala · Basic Sciences · Z01 · FY2007 · CA

Drug Resistance In Cancer Therapy

$438,437
Vinod D Labhasetwar · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · CA

Chemotherapy plus vaccine for metastatic breast cancer

$438,356
Johns Hopkins University · R01 · FY2005 · CA

Theory and Measurement of Cell Population Dynamics with Cell-Cell Interaction (TMCC)

$438,348
Sui Huang · Institute For Systems Biology · R01 · FY2019 · GM

Circadian interventions against glioblastoma

$438,347
Erik Herzog · Washington University · R01 · FY2024 · NS

Recruitment of Stromal Cells to the Tumor Microenvironment

$438,336
Robert A Weinberg · Massachusetts Institute Of Technology · U54 · FY2007 · CA

Academic-Industrial Partnership for Translation of Acoustic Angiography

$438,329
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA

NOVEL ANTITUMOR DISULFIDES

$438,319
Prolx Pharmaceuticals, Lp · R44 · FY2001 · CA

IMPROVING THE THERAPEUTIC INDEX OF ADCS TARGETING METASTATIC BREAST CANCER

$438,317
The Geneva Foundation · · FY2021 · Defense Health Agency

Integration of genetic, gene expression and environmental data to inform biological basis of mammographic density

$438,304
Sara Lindstroem · University Of Washington · R01 · FY2023 · CA

ESTABLISHING CYCLIN E/CDK2 AS A NOVEL THERAPEUTIC TARGET IN INFLAMMATORY BREAST CANCER

$438,276
University Of Texas Health Science Center At Houston · · FY2012 · Department of Defense

Targeting Cell Cycle Plasticity in Pancreatic Ductal Adenocarcinoma

$438,275
Chongmin Huan · Suny Downstate Medical Center · R21 · FY2020 · CA

Discovering the role of YES1 in triple negative breast cancer

$438,269
Ruth A Keri · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA